INSIGHTS ON DRUG DEVELOPMENT

DRUG DEVELOPMENT SOLUTIONS

  • Enhance drug solubility and bioavailability with an advanced mesoporous silica excipient that stabilizes poorly soluble compounds in their amorphous form and is backed by strong regulatory and quality support.

  • Used Carl Zeiss Microscope, with AxioCam MRc5 and H.I.P controls, CE design, serial# 39180008000.

  • Learn how peptide‑synthesis platforms, early impurity control, and optimized downstream methods boost scalability, stability, and development speed from early design to late‑stage readiness.

  • Easily analyze a diverse array of RNA species, from 50-9,000 bases, and achieve high-resolution data with a purity & integrity kit.

  • Nanoform’s proprietary bionanoparticle technology can deliver large-molecule drug particles as small as 50 nm while retaining biological activity. This can not only enable more patient-friendly approaches to drug delivery, but also potentially higher loads of active ingredients.